Medical Centre Pratia Clinic EOOD

At Medical Centre Pratia Clinic EOOD, investigators are studying Chronic lymphocytic leukemia and related blood cancers. Research also includes Multiple Myeloma and Non‑Hodgkin Lymphoma. The goal is to evaluate new therapies that reduce infection risk and improve immune function.

• Evaluation of infection‑prevention strategies
• Assessment of immune response enhancement
• Safety monitoring of combined treatments

Eight trials with four investigators underscore the centre’s focus on advancing care for hematologic disorders across Europe.

The clinic is conducting studies on Immune Thrombocytopenia (ITP) to find safer treatment options. Trials also explore novel agents that modulate immune activity in patients with low platelet counts. The primary aim is to confirm safety while reducing disease‑related bleeding.

• Dose‑escalation safety assessment
• Evaluation of platelet response
• Monitoring of adverse events

These investigations contribute to better management of autoimmune blood conditions at the Pratia site.

Researchers are testing bone‑strengthening therapies in post‑menopausal women with Post‑Menopausal Osteoporosis. A comparative study examines equivalence between a biosimilar and an established treatment. The purpose is to maintain bone density and reduce fracture risk.

• Bone mineral density measurement
• Serum marker analysis
• Long‑term safety evaluation

The work supports improved orthopedic outcomes for aging populations in Bulgaria and beyond.

In addition to hematologic cancers, the centre addresses solid‑tumor research such as Psoriatic Arthritis with an emphasis on inflammatory pathways. A trial of izokibep seeks to achieve significant symptom relief measured by standardized arthritis criteria. The study aims to demonstrate both efficacy and safety of the new biologic.

• ACR50 response evaluation
• Patient‑reported outcome tracking
• Safety and tolerability monitoring

This effort broadens the clinic’s oncology portfolio by integrating immune‑modulating approaches.

A dedicated investigation focuses on Chronic Rhinosinusitis with Nasal Polyposis. Participants receive a targeted biologic to assess reductions in nasal congestion and sinus symptoms. The objective is to improve quality of life through better disease control.

• Nasal congestion score monitoring
• Sino‑nasal outcome test assessment
• Safety profile documentation

Findings aim to enhance therapeutic options for chronic sinus conditions at the Pratia Clinic.

Seasonal protection is evaluated through a study of the adjuvanted vaccine Fluad in adults aged 65 and older. The trial compares its effectiveness to a standard influenza vaccine in preventing lab‑confirmed flu. The purpose is to confirm non‑inferior protection for the elderly population.

• RT‑PCR confirmed influenza incidence
• Immunogenicity comparison
• Adverse event surveillance

This work reinforces the centre’s commitment to public health and respiratory disease prevention.

The site also runs a trial targeting the Influenza virus to assess vaccine performance in senior adults. Researchers measure infection rates and immune response after vaccination. The study’s aim is to ensure robust protection against seasonal flu strains.

• Incidence of laboratory‑confirmed influenza
• Serological immune response analysis
• Safety and tolerability assessment

These viral investigations complement broader respiratory research efforts at Medical Centre Pratia Clinic EOOD.